资本配置出错，往往是业务量最大的股权合伙人拿到下一个收费律师，而不是能提升下一笔收入的变现率或利用率的业务组。 律所面临具体约束——28名股权合伙人中有19人已满55岁，八年未设正式横向招聘计划或律师转合伙人通道。在这一约束定价前，82%的变现率会持续变动而无人能归因，按条线回报的争论仍只是意见之争。
资本配置出错，往往是业务量最大的股权合伙人拿到下一个收费律师，而不是能提升下一笔收入的变现率或利用率的业务组。 律所面临具体约束——28名股权合伙人中有19人已满55岁，八年未设正式横向招聘计划或律师转合伙人通道。在这一约束定价前，82%的变现率会持续变动而无人能归因，按条线回报的争论仍只是意见之争。
多数律所按历史和口才分配：去年分到相同收费律师的业务组今年继续拿到，股权合伙人在合伙人会议上争得最凶的拿到增量。这两者都与下一个收费律师能提升哪一组的变现率或减少锁定期无关。
有效的分析按两项指标给每个业务组排序——每增加一名收费律师能给股权合伙人带来多少增量利润，以及这一回报能维持多久。能提升利用率但一年内变现率下降的组，与能长期维持82%变现率和68%利用率的组不是同一回事，把它们等同对待就是资助衰退。
输出应是一条带停止规则的序列，而不是在五组间切分预算。哪一组先拿到下一个收费律师，它必须在利用率或锁定期上产出什么，以及什么观察会说明序列已错。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 收费律师增补按去年的分配再加一个百分比获批
✓ 没有股权合伙人能说出五个业务组各自的每股权合伙人增量利润
✓ 申请新收费律师时用战略重要性或合伙人工作量辩护，而非变现率、利用率或锁定期的数据变化
通常会让情况更糟的做法。 把新收费律师平均分配给五个业务组以维持股权合伙人一致，结果让本可复利提升利用率或变现率的组长期缺人。
It is for you if you run or finance a law firm and budgets are set by last year plus a percentage. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家律所. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Ashgrove Legal LLP, a sample company profile used for testing rather than a customer — £24.8 m gross revenue from five practice groups.
Excerpt from a real Percision run · Quick Market Scan · sample company profile
The move. Scale the only practice hitting 88 % realisation to fund its own growth and close the succession gap.
| Investment required | £240 k (remaining FY2026 discretionary cap after £180 k IT commitment) |
| Expected return | 1.4–1.6× cash-on-cash within 24 months at current realisation rates. |
| Revenue, year 1 | £25.4–25.7 m firm-wide (+£0.6–0.9 m incremental) |
| Revenue, year 2 | £26.5–27.1 m firm-wide (+£1.1–1.3 m incremental from B&F segment) |
| Revenue, year 3 | £27.8–28.6 m firm-wide (+£1.3–1.5 m incremental) |
| Exit criteria | Strategy must be reversed if, within 18 months, segment revenue has not reached £2.4 m annualised OR cumulative net profit contribution is below £150 k, OR if any lateral hire’s personal billings fall below 1 200 hours in any rolling 6-month period. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Growth Portfolio Framework, one of 29 engagements the platform runs. For 律所 it works through 82 % realisation, 68 % utilisation, £184 k profit per equity partner and 112 lock-up days, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
明确给耐久性定价。衰减的回报需要给出半衰期；一旦每个选项都带上这一数值，不同跨度的选项就能比较，而非只凭偏好。
通常投最强部分，因为边际资金在那里复利。修最弱部分只有在它构成对最强部分的约束时才值得，否则不必。
看可逆性。两个选项回报相近时，选能停掉的，因为买到的信息价值超过估算差值。
Materially, yes. 19 of 28 equity partners aged 55 or over with no formal lateral hire programme or associate-to-partner track for eight years — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 82 % realisation, 68 % utilisation, £184 k profit per equity partner, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 82 % realisation and 68 % utilisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית